Further PNPLA3 interactions relative to NAFLD were reported in another study that determined that the I148M mutant of PNPLA disrupted ubiquitylation and negatively impacted the degradation of PNPLA3. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.